3000 patients join study to unravel brain clot mystery
NCT ID NCT03919305
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is following 3000 people in China who have cerebral venous thrombosis, a rare type of blood clot in the brain. Researchers will collect blood and spinal fluid samples to learn more about the disease and find markers that could help with diagnosis. The goal is to better understand the condition and how it is currently treated.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better understanding and earlier diagnosis of cerebral venous thrombosis.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly improve outcomes for participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL VENOUS SINUS THROMBOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xuanwu Hospital, Capital Medical University
RECRUITINGBeijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- French biobank aims to unlock secrets of rare brain vessel diseases
- Blood tests may help predict recovery in rare brain clot condition
- New hope for severe brain clots: clot removal plus meds vs. meds alone
- Brain vein study tests new MRI to see lymph nodes
- Snake venom enzyme could boost stroke recovery in rare brain clot study
- Eye ultrasound could replace needles for measuring brain pressure in kids